Home › DexCom Announces Appointment of Mark G. Foletta as Board Member
 

Keywords :   


DexCom Announces Appointment of Mark G. Foletta as Board Member

2014-11-20 13:05:04| Steel - Topix.net

Mr. Foletta currently serves on the board of directors of AMN Healthcare Services and Regulus Therapeutics. Previously, Mr. Foletta served as Senior Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc. from 2006 to August 2012 during the growth of Amylin's diabetes and obesity franchises, including the commercial launch of diabetes drugs BYDUREONA , BYETTAA and SYMLINA .

Tags: member board mark appointment

Category:Materials

Latest from this category

All news
»
05.10Hurricane Leslie Graphics
05.10Hurricane Leslie Forecast Discussion Number 11
05.10Hurricane Leslie Wind Speed Probabilities Number 11
05.10Hurricane Leslie Public Advisory Number 11
05.10Summary for Hurricane Leslie (AT3/AL132024)
05.10Hurricane Leslie Forecast Advisory Number 11
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 23
More »